An official website of the United States government
Here's how you know
Official websites use .mil
A
.mil
website belongs to an official U.S. Department of Defense organization in the United States.
Secure .mil websites use HTTPS
A
lock (
lock
)
or
https://
means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.
Skip to main content (Press Enter).
Toggle navigation
JPEO-CBRND
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
JPEO-CBRND
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Search
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Home
About
Leadership
Joint Project Managers & Joint Project Leads
Our Story
Resources
Media
News
Photography
Work With Us
JETT - Joint Enterprise Technology Tool
SPARK
Careers
Contact
News
1
2
3
4
5
Results:
Tag:
COVID -19
JPEO-CBRND Embraces the Need for Speed in Biodefense: How JPEO is Shaping its Biological Defense and Medical Strategies
August 11, 2023
— Biological incidents possess an alarming ability to wreak havoc on a massive scale, capable of rapidly escalating beyond the scale seen during COVID-19. The need lies in developing solutions that surpass the speed of these threats. Our warfighters need to swiftly defend themselves against a biological threat, or better yet, prevent it entirely, to...
MORE
Capacity Expansion Team Bolsters Nation’s Vaccine Industrial Base in Response to COVID-19
April 27, 2023
— At the height of the COVID-19 pandemic, supply chain shortfalls prevented Americans from finding basic items like toilet paper and cleaning supplies. Factory shutdowns emphasized the fact that most American manufacturing took place overseas. The domino effect was felt far and wide and was further illuminated once COVID-19 vaccines were available to...
MORE
Lawyers and Pandemic Response: How the Joint Assisted Acquisition (JA2) Legal Cell Joined the Fight Against COVID-19
April 18, 2023
— President Biden announced that in May 2023, the U.S. will officially end its emergency response posture to the COVID-19 pandemic. This announcement marks a significant milestone in a long and difficult journey. From masks, to at-home test kits, to vaccines, countless experts worked tirelessly behind the scenes to develop the products and solutions...
MORE
NSWC Crane employee serves public health overseeing $900M portfolio as U.S. expands vaccine and therapeutic manufacturing supply chain
December 14, 2022
— A Naval Surface Warfare Center, Crane Division (NSWC Crane) employee is serving on a detail overseeing a $900 million portfolio to expand the U.S. vaccine and therapeutic manufacturing supply chain. Over the past two years, these investments and partnerships with industry have developed into the construction of new manufacturing facilities across the country to develop future vaccine and therapeutic capabilities. The JPEO-CBRND and the Army Contracting Command were leveraged to assist the Biomedical Advanced Research and Development Authority, which is an office in the U.S. Department of Health and Human Services, who were tasked in 2020 to ensure that every COVID-19 vaccine, therapeutic, and test kit were bought, packaged, and delivered to the Nation. The JPEO-CBRND has a special Joint Assisted Acquisition (JA2) team, established by the May 2021 memorandum of understanding between DoD and HHS, which supports the continued contracting and acquisition expertise needed for the Nation’s ongoing mission to fight the coronavirus, including partnerships with the Federal COVID-19 Response interagency team, academia and the American industrial base...
MORE
DoD Awards $1.74 Billion Agreement to Moderna, Inc. to Secure Over 65 Million Doses of COVID-19 Vaccine for Fall Vaccinations
July 29, 2022
— On July 28, 2022, the Department of Defense (DoD), on behalf of and in coordination with the U.S. Department of Health and Human Services (HHS), awarded a $1.74 billion agreement to purchase over 65 million doses of Moderna’s COVID-19 vaccine for a fall vaccination campaign. The vaccine will target the SARS-CoV-2 Omicron subvariant viruses, as...
MORE
Biden-Harris Administration secures 3.2 million doses of Novavax COVID-19 Vaccine
July 11, 2022
— Latest vaccine will provide an additional option for the American public, pending FDA Emergency Use Authorization and CDC recommendation...
MORE
Biden-Harris Administration Secures More Than 100 Million Doses of Pfizer's Latest COVID-19 Vaccine for Fall Vaccine Campaign
June 29, 2022
— The U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense (DOD), announced an agreement to purchase more than 100 million doses of Pfizer’s COVID-19 vaccine for a fall vaccine campaign. The contract announcement follows a June 28, 2022 meeting of the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee, which recommended the inclusion of an Omicron component for COVID-19 booster vaccines in the U.S. To award the contract, the Biomedical Advanced Research and Development Authority (BARDA), part of ASPR, collaborated with the DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) who led this effort in partnership with the Defense Assisted Acquisition Cell (DA2) and U.S. Army Contracting Command...
MORE
DOD Awards $79.9 Million Contract to Premix, Inc. to Onshore Production Capacity of Resin for Pipette Tips Required for COVID-19 Diagnostic Testing
May 11, 2022
— On May 5, 2022, the Department of Defense (DOD), on behalf of and in coordination with the U.S. Department of Health and Human Services (HHS), awarded a $79.9 million contract to Premix, Inc. to establish production of a plastic compound primarily used for pipette tips, which are essential to COVID-19 and other diagnostic testing efforts. Premix,...
MORE
DoD Awards Contract Modifications to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS’ One Billion Free At-Home COVID-19 Tests
March 28, 2022
— In the month of March, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contract modifications to Abbott Rapid Dx North America, LLC (Orlando, Florida) and iHealth Labs Inc. (Sunnyvale, California), purchasing an additional 176.8 million over-the-counter COVID-19 test kits. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). The procurement was funded through the American Rescue Plan Act to supply critical medical resources to the nation...
MORE
DOD Awards Contracts to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS’ One Billion Free At-Home COVID-19 Tests
February 18, 2022
— This week, the DoD, in coordination with HHS, awarded contract modifications to Roche Diagnostics Corporation and Siemens Healthineers purchasing a combined total of 138 million over-the-counter COVID-19 test kits. The JPEO-CBRND led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). The procurement was funded through the American Rescue Plan Act to supply critical medical resources to the nation...
MORE
1
2
3
4
5
News Search
News Archive - Search by Year and Month
2024 (37)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)
JPEO-CBRND Press Kit
Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.
JPEO-CBRND Public Affairs Office
The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.